Tag: KPMG

‘FinTech: The growth propeller for MSMEs’

Demonetisation affected many people in many ways. But the most to feel the heat were small and medium business owners. Largely a cash intensive market, scrapping of Rs 500 & Rs 1000 notes and scarcity of lower denomination notes drove them to adopt digital payment tools to keep the business g…

NPA की हकीकत: बैंकों के डूबते कर्ज का उद्योगों से लेकर हर किसी की जिंदगी पर असर

‘बैड डेट’, ‘एनपीए’ या ‘स्ट्रेस लोन’ जैसे शब्द आजकल आम आदमी की जुबान पर भी आ गए हैं. और ये तथ्य देश के बैंकिंग सेक्टर की डरावनी असलियत को बताने के लिए काफी है. दरअसल, पिछले कुछ सालों में बैंकों के नॉन परफॉर्मिंग एसेट्स यानी एनपीए इतनी तेजी से बढ़े हैं कि अब इन पर चर्चा सिर्फ […]

Naidu launches AP MSME Development Corporation with Rs 100 cr corpus

AP & Telangana vying for top honours in start-up ecosystem

Last month Andhra Pradesh’s coastal city Visakhapatnam, or Vizag, was buzzing with financial technology startups showcasing products, competing in front of various stakeholders and help ring in Chief Minister Chandrababu Naidu’s vision to make Vizag the fintech hub of India. “By…

70% of India’s small, mid-sized firms yet to start GST preparations

About 70% of the country’s small and mid-sized firms are yet to begin preparations to get synced with the goods and services tax (GST) structure even as the country prepares to roll out the biggest indirect tax reform from July 1. Consulting major KPMG and the Federation of Small Medium Enterpris…

Healthcare start-ups revolutionising Indian healthcare?

Indian Healthcare sector is one of the largest sectors contributing to 6% of the country’s GDP. Yet, with 21% of world’s disease burden, the doctor patient ratio being as bad as 1:1700 and out of pocket expenditure as high as 62% of total healthcare spending, the sector is riddled with structural…

Why most healthcare start-ups are bleeding

Ahmedabad: Not many digital healthcare start-up has achieved break-even mainly because of the absence of ‘assisted e-commerce’ in an industry driven mostly by doctors, pharmaceutical companies and their associations. Slow growth, difficulty in getting all the stakeholders, including consumers, on…